The Global Virome in Health and Disease
Organizer(s): David Wang, Frederic D. Bushman and Mya Breitbart Date: March 01 - 04, 2020
Location: Granlibakken Tahoe, Tahoe City, CA, USA
For important information on the coronavirus, please click here
Viruses are the most abundant biological entities on earth, but only recently has it been possible to define the full virome in humans, animals, plants and global environments. Virome signatures have been associated with diverse conditions such as HIV/AIDS, inflammatory bowel disease, malnutrition, graft versus host disease, organ transplantation, and type 1 diabetes, providing novel insights into mechanisms of pathogenesis. Recently, various beneficial roles of the virome have also been identified, thereby broadening our understanding of the commensal microbiome. However, despite these advances, the vast majority of the virome remains undiscovered, and thus many associations with health and disease have yet to be identified. The goals of this conference are to examine the state-of-the art in virome studies, including efforts to define the virome, establish linkages with health and disease, understand interactions between viral and bacterial components of the microbiome, exploit new model systems, and identify mechanisms of immune control. This will be the first conference dedicated solely to the virome, bringing together experts in eukaryotic virology, phage biology, genomics, informatics, public health, model organisms, and immunology. This conference will bridge the distinct research communities that study bacterial and eukaryotic viruses and unify host-based and environmental research frameworks to allow potent new synergies.
Scholarship Deadline: October 30 2019
Discounted Abstract Deadline: October 30 2019
Abstract Deadline: November 21 2019
Discounted Registration Deadline: December 19 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email email@example.com if you are interested.
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI149881-01
Funding for this conference was made possible (in part) by 1R13AI149881-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.